Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
The Finish Line Inc. (FINL - Snapshot Report) posted adjusted earnings per share of 80 cents in the fourth quarter of fiscal 2012, beating the Zacks Consensus Estimate by a penny. The quarterly earnings bettered the year-ago results by 17 cents. In full-fiscal 2012, earnings per share were $1.59 versus $1.26 per share in 2011.
Indianapolis based Finish Line reported year-over-year net sales growth of 18.6% in the quarter to $456.3 million backed by strong comparable sales (comps). Comps increased 11%, with store comps growing 7% and digital comps climbing 38%. In full-fiscal 2012, revenue increased 11.4% year over year to $1,369.3 million.
The 53rd week of fiscal 2012 infused an additional $30.5 million to the fourth quarter net sales and 7 cents to the earnings per share.
By category, footwear comps were up 11.1% while soft good’s comps rose 9.4%. Footwear witnessed average selling price rise of 3.0% in the fourth quarter.
During the quarter, Finish Line’s gross profit increased 22.6% year over year to $169.5 million. Gross margin expanded100 basis points year over year to 37.2%.
Financials
At quarter end, Finish Line had cash and cash equivalents of $307.5 million, compared with $299.3 million in the year-ago period. The company had no interest-bearing debt.
Finish Line bought back 300,000 million shares in the fourth quarter, totaling $5.9 million. The company has now 3.8 million shares left over on its authorization of 5 million shares.
Store Update
Finish Line did not open any store during the quarter but closed 11. The company ended the year with 637 units.
Outlook
This premium retailer of athletic shoes, apparel and accessories is in a strong product cycle for athletic footwear. The uptrend comps will continue to bode well for the company. Finish Line‘s March comps increased 10.0% on top of an 8.0% increase for the same period a year ago. The trend calls for a strong first quarter ahead in which the company expects comps to be up in the mid-single digit range.
However, management embarked on a set of initiatives to spur technology, stores and digital capabilities and consequently invested substantially. This will lead to increased SG&A expenses resulting in constrained operating margins in 2013. The company expects first quarter earnings per share to be down approximately 30%. However, management expects earnings to pick up beginning fiscal 2014, as the investments begin to reap returns.
Finish Line, which competes with Genesco Inc. (GCO - Snapshot Report) currently, retains a Zacks #1 Rank (short-term Buy rating). For the long term, we reiterate our Neutral recommendation on the stock.
Get the full Snapshot Report on GCO - FREE
Get the full Snapshot Report on FINL - FREE